Fig. 6

Comparison of OS between the AC and Non-AC groups according to pathological stage in high IPI subpopulation of the PSM cohort. AÂ Stage II-III patients with high IPI. CÂ Stage II patients with high IPI. EÂ Stage III patients with high IPI; Comparison of DFS between the AC and Non-AC groups according to pathological stage in high IPI subpopulation of the PSM cohort. BÂ Stage II-III patients with high IPI. DÂ Stage II patients with high IPI. FÂ Stage III patients with high IPI